UPDATE: Important information about LabCorp's response to COVID-19 Read more >>>

News Releases

Webcast
Q2 2020 Laboratory Corporation of America Holdings Earnings Conference Call
Jul 28, 2020 at 9:00 AM EDT
Date Title and Summary Additional Formats
Jul 09, 2020
LabCorp’s Insight Analytics Reports Help Healthcare Organizations Identify Trends for High-Risk Health Conditions and Improve Quality of Care
Reports utilize LabCorp testing data related to conditions that have co-morbidities with other serious diseases, including increased COVID-19 risk BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 9, 2020-- LabCorp (NYSE: LH), a leading global life sciences company deeply integrated in guiding patient care,
Jul 07, 2020
LabCorp Launches First Digital COVID-19 Service That Improves the Doctor and Patient Experience
Convenient LabCorp At Home Service Aims to Help Patients Resume Health Care, Treatments, and Surgeries BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 7, 2020-- LabCorp (NYSE: LH) today launched the LabCorp At Home COVID-19 Test Collection Service, the first seamless digital service aimed at helping
Jul 06, 2020
LabCorp to Announce Second Quarter Financial Results on July 28, 2020
BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 6, 2020-- LabCorp (NYSE: LH) will release its second quarter of 2020 financial results before the market opens on Tuesday, July 28, 2020 , and then will host a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results.
Jun 29, 2020
LabCorp Introduces Xcellerate® COVID-19 Clinical Study Solution
Advanced Analytics and Visualizations Empower Study Teams to Respond to Dynamic Environment, Manage Risk, Resume Studies and Safeguard Patients BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 29, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient
Jun 25, 2020
LabCorp Launches New Neutralizing Antibody Test
Neutralizing Antibody Assay Could Be Used to Assist in Development of COVID-19 Vaccines and Plasma-Based Treatments BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 25, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced the
Jun 16, 2020
Brian Caveney, Chief Medical Officer and President of LabCorp Diagnostics, Named to Modern Healthcare's 50 Most Influential Clinical Executives List
BURLINGTON, N.C., June 16, 2020 — LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that Dr. Brian Caveney, chief medical officer and president of LabCorp Diagnostics, was recognized by Modern Healthcare as one of this
Jun 01, 2020
LabCorp Launches New COVID-19 Clinical Trial Site to Connect Patients With U.S. Research Trials
Streamlining recruitment into studies to speed research BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 1, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that Covance, its drug development business, has created COVID-19
May 28, 2020
LabCorp Accelerates Adoption of Decentralized Clinical Trials, Expands Technology Ecosystem Through Alliance With Medable
BURLINGTON, N.C. --(BUSINESS WIRE)--May 28, 2020-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that Covance, its drug development business, is expanding its technology ecosystem to accelerate the adoption of
May 19, 2020
Roche highly accurate antibody test for COVID-19 goes live at more than 20 initial lab sites in the US
LabCorp and other commercial labs will have the ability to perform more than 2 million tests per week by June INDIANAPOLIS , May 19, 2020 /PRNewswire/ -- Roche (SIX: RO, ROG;OTCQX: RHHBY ) today announced its Elecsys® Anti-SARS-CoV-2 antibody test is live at more than 20 commercial and hospital lab
May 14, 2020
LabCorp Launches Return to Work Services for Employers
Employers Now Have Access to LabCorp’s High-Quality COVID-19 Testing Capabilities Including Its New Fingerstick Antibody Blood Test BURLINGTON, N.C. --(BUSINESS WIRE)--May 14, 2020-- LabCorp (NYSE: LH) announced today it is launching a new return to work service for employers. Many U.S.
May 12, 2020
LabCorp Significantly Expands Availability of Its COVID-19 At-Home Collection Test Kit
Consumers Now Have Access to the At-Home Test Collection Kit Online with No Upfront Costs, In Addition to Healthcare Workers and First Responders BURLINGTON, N.C. --(BUSINESS WIRE)--May 12, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding
May 06, 2020
LabCorp Is Scheduled to Present at the Bank of America Securities 2020 Health Care Conference
BURLINGTON, N.C. --(BUSINESS WIRE)--May 6, 2020-- LabCorp (NYSE: LH) today announced that members of the executive management team will participate in a virtual fireside chat at the Bank of America Securities 2020 Health Care Conference on Wednesday, May 13 , at 10:20 a.m. ET .
May 05, 2020
COVID-19 Antibody Test Now Directly Available Through LabCorp.com
Expanding Access to Tests Through LabCorp’s Wide Network of Doctors, Healthcare Providers, and Now Online BURLINGTON, N.C. --(BUSINESS WIRE)--May 5, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that its COVID-19
May 05, 2020
LabCorp to Webcast Its Annual Meeting of Shareholders
BURLINGTON, N.C. --(BUSINESS WIRE)--May 5, 2020-- LabCorp (NYSE: LH) today announced that its Annual Meeting of Shareholders will be webcast live beginning May 13 , at 9:00 a.m. Eastern Daylight Time via the company website at www.LabCorp.com . An archived replay of the audio webcast will be
Apr 29, 2020
LabCorp Announces 2020 First Quarter Results
Q1 revenue of $2.82 billion , up 1% over $2.79 billion last year Q1 diluted EPS of ( $3.27 ), which include goodwill and other asset impairments of $4.43 per share Q1 adjusted EPS of $2.37 , which were negatively impacted by an estimated $0.55 per share from the COVID-19 pandemic Q1 free cash flow
Apr 27, 2020
LabCorp COVID-19 Antibody Tests Available Nationwide With No Upfront Out-of-Pocket Costs
Locations include nearly 2,000 LabCorp patient service centers including more than 100 LabCorp at Walgreens locations, and thousands of physicians’ offices BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 27, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in
Apr 22, 2020
LabCorp Broadens Availability of COVID-19 Serological Antibody Tests to Hospitals, Healthcare Organizations and Through Its Patient Service Centers
Tests Assist in Confirming the Presence of Antibodies to the Virus that Causes COVID-19 BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 22, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced it will expand serological
Apr 21, 2020
LabCorp COVID-19 At-Home Test Kit Receives FDA Emergency Use Authorization
Initial Distribution Prioritized for Frontline Healthcare Workers and First Responders BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 21, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that it has received an Emergency
Apr 09, 2020
LabCorp and Ciox Health Enter Collaboration to Create Comprehensive Patient Data Registry
Groundbreaking Registry Aims to Help Researchers Accelerate COVID-19 Diagnosis, Treatment and Prevention Strategies BURLINGTON, N.C. & ALPHARETTA, Ga. --(BUSINESS WIRE)--Apr. 9, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, and
Apr 08, 2020
Pacific Biosciences Powers SARS-CoV-2 Research at Commercial, Academic and Government Labs
LabCorp, UC San Diego and the National Institute of Allergy and Infectious Diseases are among the organizations utilizing PacBio’s highly accurate long-read sequencing technology to study SARS-CoV-2 and the related immune response to COVID-19   MENLO PARK, Calif., April 8, 2020 — Pacific
Apr 06, 2020
LabCorp to Announce First Quarter Financial Results on April 29, 2020
BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 6, 2020-- LabCorp (NYSE: LH) will release its first quarter of 2020 financial results before the market opens on Wednesday, April 29, 2020 , and then will host a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results.
Mar 23, 2020
LabCorp Developing Options to Prioritize COVID-19 Testing for Inpatient Population in Support of Guidance from the White House Coronavirus Task Force
Company also preparing to support faster point-of-care testing for COVID-19 in hospitals once available BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 23, 2020-- LabCorp (NYSE: LH), a leading global life services company that is deeply integrated in guiding patient care, today announced that it is
Mar 20, 2020
Adaptive Biotechnologies and Microsoft expand partnership to decode COVID-19 immune response and provide open data access
Differentiated approach may improve detection methods and inform vaccine discovery for COVID-19 Other industry leaders including LabCorp, through its Covance drug development business, Illumina, and Providence join forces to accelerate this critical effort SEATTLE and REDMOND, Wash.
Mar 19, 2020
LabCorp Sets Dedicated Hours to Serve the Non-COVID-19 Testing Needs for Elderly and Most Vulnerable People
LabCorp ‘Wait Where You’re Comfortable’ and Mobile Check-In Options Reinforce Social Distancing Protocols BURLINGTON, N.C. --(BUSINESS WIRE)-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that it is dedicating the
Mar 05, 2020
LabCorp Launches Test for Coronavirus Disease 2019 (COVID-19)
The LabCorp 2019 Novel Coronavirus (COVID-19), NAA Test is for Use by Clinicians with Patients Who Meet COVID-19 Evaluation Criteria BURLINGTON, N.C. --(BUSINESS WIRE)-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, is making its